Pathologic Predictors of Microsatellite Instability in Colorectal Cancer

被引:194
|
作者
Greenson, Joel K. [1 ]
Huang, Shu-Chen [2 ]
Herron, Casey [2 ]
Moreno, Victor [2 ,3 ]
Bonner, Joseph D. [2 ]
Tomsho, Lynn P. [2 ]
Ben-Izhak, Ofer
Cohen, Hector I. [6 ]
Trougoubhoff, Phillip [7 ]
Bejhar, Jacob
Sova, Yanina [5 ]
Pinchev, Mila [4 ]
Rennert, Gad [4 ]
Gruber, Stephen B. [2 ]
机构
[1] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan Hlth Syst, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA
[3] Univ Barcelona, Inst Catala Oncol, Unitat Bioestadist & Bioinformat, Barcelona, Spain
[4] Technion Israel Inst Technol, IL-32000 Haifa, Israel
[5] Carmel Hosp, Haifa, Israel
[6] Western Galilee Med Ctr, Nahariyya, Israel
[7] Haemek Med Ctr, Afula, Israel
关键词
colorectal neoplasia; microsatellite instability; pathology; tumor-infiltrating lymphocytes; mucinous; differentiation; dirty necrosis; logistic regression; TUMOR-INFILTRATING LYMPHOCYTES; COLON-CANCER; ADJUVANT CHEMOTHERAPY; LYNCH-SYNDROME; MISMATCH REPAIR; BETHESDA GUIDELINES; SURVIVAL BENEFIT; PROXIMAL COLON; FEATURES; POPULATION;
D O I
10.1097/PAS.0b013e31817ec2b1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Identification of microsatellite unstable (MSI-H) colorectal cancers (CRCs) is important not only for the identification or hereditary nonpolyposis colorectal cancer syndrome but also because MSI-H CRCs have. a better prognosis and may respond differently to 5-Florouracil-based chemotherapy. We present 2 nearly equivalent logistic regression models for clinical use that predict microsatellite instability based on the review of 1649 CRCs front patients of all ages collected in a population-based case control study in northern Israel. One hundred ninety-eight of these 1649 tumors demonstrated it high degree of microsatellite instability (12%). Multivariate analysis Found that > 2 tumor-infiltrating lymphocyte (TIL) cells per high-powered field, the lack of dirty necrosis. the presence of it Crohn-like reaction, right-sided location, any mucinous differentiation (mucinous or focally mucinous) and well or poor differentiation, and age less than 50 were all independent predictors of MSI-H. We developed 2 logistic regression models that differ only by the statistical approach used to analyze the number of TIL cells per high-powered field, where the slightly more accurate (and complex) model uses the log of the total number of TIL cells. The simpler clinical model uses it cut-off of 2 > TIL cells per high-powered field. The accuracy of both models is high. with an 85.4% versus 85.0%, probability of correctly classifying tumors as MSI-H. By employing the simpler model, pathologists can predict the likelihood of microsatellite instability by compiling the MSI probability score (Table 4 and Fig. 1) from simple histologic and clinical data available during sign-out. Our model shows that approximately 43% of CRCs have a MSI probability score of 1 or less and hence have little likelihood ( < 3%) of being MSI-H. Although this model is not perfect in predicting microsatellite instability. its use Could improve the efficiency of expensive diagnostic testing.
引用
收藏
页码:126 / 133
页数:8
相关论文
共 50 条
  • [21] Underuse of Microsatellite Instability Testing and Predictors of High Microsatellite Instability Disease Among Young Colorectal Cancer Patients in the United States
    Shaikh, T.
    Handorf, E. A.
    Hall, M.
    Meyer, J. E.
    Esnaola, N. F.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S164 - S164
  • [22] The pathology of microsatellite instability in colorectal cancer
    Gryfe, R
    Gallinger, S
    Holowaty, E
    Bapat, B
    Redston, M
    [J]. MODERN PATHOLOGY, 1998, 11 (01) : 65A - 65A
  • [23] Histopathological Predictors of Microsatellite Instability in Colorectal Cancer-a Tertiary Care Center Experience
    Aminder, Singh
    Saveena, Jindal
    Ankita, Soni
    Harpreet, Kaur
    Kunal, Jain
    Vikram, Narang
    Sumit, Grover
    Bhavna, Garg
    Ramneek, Kaur
    [J]. INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (01) : 137 - 143
  • [24] Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines
    Arakawa, Keiichi
    Hata, Keisuke
    Kawai, Kazushige
    Tanaka, Toshiaki
    Nishikawa, Takeshi
    Sasaki, Kazuhito
    Shuno, Yasutaka
    Kaneko, Manabu
    Hiyoshi, Masaya
    Emoto, Shigenobu
    Murono, Koji
    Nozawa, Hiroaki
    [J]. ANTICANCER RESEARCH, 2018, 38 (08) : 4871 - 4876
  • [25] Clinical and pathologic significance of microsatellite instability in endometrial cancer
    Wong, YF
    Ip, TY
    Chung, TKH
    Cheung, TH
    Hampton, GM
    Wang, VW
    Chang, AMZ
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (05) : 406 - 410
  • [26] Microsatellite pathologic score does not efficiently identify high microsatellite instability in colorectal serrated adenocarcinoma
    Garcia-Solano, Jose
    Conesa-Zamora, Pablo
    Carbonell, Pablo
    Trujillo-Santos, Javier
    Torres-Moreno, Daniel
    Rodriguez-Braun, Edith
    Vicente-Ortega, Vicente
    Perez-Guillermo, Miguel
    [J]. HUMAN PATHOLOGY, 2013, 44 (05) : 759 - 765
  • [27] Clinical significance of microsatellite instability in colorectal cancer
    Kloor, Matthias
    Staffa, Laura
    Ahadova, Aysel
    Doeberitz, Magnus von Knebel
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2014, 399 (01) : 23 - 31
  • [28] Mitochondrial microsatellite instability of colorectal cancer stroma
    Kim, Hong Sug
    Lim, Hee Sun
    Lee, Sug Hyung
    Lee, Jong Woo
    Nam, Suk Woo
    Park, Won Sang
    Lee, Youn Soo
    Lee, Jung Young
    Yoo, Nam Jin
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (11) : 2607 - 2611
  • [29] Clinicopathologic characteristics of colorectal cancer with microsatellite instability
    Ziadi, S.
    Ksiaa, F.
    Ben Gacem, R.
    Labaied, N.
    Mokni, M.
    Trimeche, M.
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (02) : 98 - 104
  • [30] Prognosis of colorectal cancer with microsatellite instability.
    Benatti, P
    Marino, M
    Gafà, R
    Barana, D
    Pedroni, M
    Scarselli, A
    Di Gregorio, C
    Roncucci, L
    Oliani, C
    Lanza, G
    de Leon, MP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 258S - 258S